Stanford has established guidance whereby human subjects and external research study personnel comply with the CDC guidance for self-isolation and self-quarantine. This means that certain prospective visitors are not permitted to visit Stanford facilities to participate in research activities, including people who:
- Have been diagnosed with COVID-19 (tested positive)
- Exhibit symptoms of COVID-19 (fever, cough, sore throat, shortness of breath, vomiting, diarrhea)
- Have recently returned from travel to locations with CDC travel restrictions
- May have had close contact with known cases
- Believe they may have been exposed to COVID-19 virus
Any non-essential visits should be postponed whenever possible. Non-essential research activities should be deferred if possible. New studies that have not yet started, especially those having a large population of human subjects, should also be deferred if possible.
Study teams may implement exceptions to allow for clinical trials treatments of patients with serious illnesses. Study teams may implement exceptions to allow, for example, clinical trials treatments of patients with serious illnesses, or other essential studies. Study teams should also evaluate and implement additional mitigation measures for work with immunocompromised study participants, older adults, and patients.
In an effort to minimize exposure during the COVID-19 outbreak, study teams should contact all study participants, study monitors, and other external research study personnel prior to appointments to ensure their suitability for in-person visits.
Please ask your visitors the day prior to their scheduled appointment to confirm that they are not in, nor are candidates for, self-isolation or self-quarantine. If they are ill/symptomatic, please postpone their involvement in your study.
Visits to the hospital should be limited to essential personnel only.
Staff, students and all research study personnel should observe social distancing, respiratory etiquette, and frequent handwashing. Stanford researchers who are people at higher risk (older adults, people with chronic, serious medical conditions) are advised to follow CDC guidance to reduce their risk of illness, and work with their managers on specific arrangements that may be needed to reduce risk.
For shared research equipment (e.g., keyboards, chin rests, table tops), please wipe down with disinfectant prior to and after subject participation.
Procedures and processes may need to be changed with little notice, due to the dynamic nature of the situation. Please continue to monitor healthalerts.stanford.edu/covid-19 for current information. We aim to best protect study participants and staff while continuing research as possible under conditions of the COVID-19 virus outbreak. We appreciate your understanding and flexibility.
If you have a question, please email it to email@example.com where it will be routed to the appropriate person for a response.